Phase 1 clinical trial of unique COVID-19 vaccine begins 04/05/2021 Health News, A unique vaccine to protect against COVID-19 begins clinical testing Tuesday, 6 April, at the...
Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia 10/15/2020 Health News, EIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate...
Promising COVID-19 rapid test technology enters phase 1 of NIH challenge 10/01/2020 Health News, A promising new COVID-19 rapid-testing technology platform developed by Rover Diagnostics and Columbia Engineering has...
World in ‘new and dangerous phase’ of pandemic: WHO 06/19/2020 Health News, Source: Read Full Article
Urovant Sciences Announces Positive Topline Results from Pivotal Phase 3 EMPOWUR Study of Vibegron in Patients with Overactive Bladder 03/20/2019 Medications, IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Mar. 19, 2019-- Urovant Sciences (Nasdaq: UROV),a clinical-stage biopharmaceutical company...
Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis 03/20/2019 Medications, DUBLIN, March 12, 2019 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the...
Pfizer Initiates Phase 2b/3 Clinical Trial for PF-06651600, an Oral JAK3 Inhibitor, for the Treatment of Patients with Moderate to Severe Alopecia Areata 01/05/2019 Medications, January 3, 2019 -- Pfizer Inc. (NYSE: PFE) announced today the initiation of a Phase...
Incyte Announces First Patient Treated in Phase 3 Clinical Trial Program for Ruxolitinib Cream in Atopic Dermatitis 12/28/2018 Medications, WILMINGTON, Del.--(BUSINESS WIRE)--Dec. 20, 2018-- Incyte (Nasdaq:INCY) today announced that the first patient has been...
Isofol Announces Initiation of a Pivotal Phase 3 Clinical Trial of arfolitixorin for the Treatment of Metastatic Colorectal Cancer 11/19/2018 Medications, GOTHENBURG, Sweden, November 15, 2018 – Isofol Medical AB (publ), (Nasdaq First North Premier: ISOFOL)...
Phase III Trial of Darolutamide in Patients with Non-metastatic Castration-resistant Prostate Cancer Meets Primary Endpoint 11/08/2018 Medications, WHIPPANY, N.J., Oct. 24, 2018 /PRNewswire/ -- The Phase III ARAMIS (Androgen Receptor inhibiting Agent...